Products
Applications & Insights
Knowledge & Support
About QIAGEN
Quick Order
0
Cart
My QIAGEN
Experiment Configurator
Discovery & Translational Research
Diagnostics & Clinical Research
Human ID & Forensics
Next-Generation Sequencing
Instruments & Automation
Informatics & Data
Services
OEM by QIAGEN
Top Sellers
New Solutions
Shop
Applications & Insights Overview
Research & Technology
Diagnostic & Clinical
Applied & Industrial
Digital Tools & Platforms
Plan your experiment
Knowledge & Support Overview
Service Solutions
Events & Webinars
Safety Data Sheets
Knowledge Hub
Quality, Environmental, Health & Safety
Product & Technical Support
Ordering Support
Resources
Product FAQ
About Us
Careers
Investor Relations
Newsroom
Customer stories
Sustainability
Compliance
Contact Us
TB Management
QuantiFERON-TB Gold Plus
Transplant
QuantiFERON Transplant
artus Viral Load
Infectious Disease
QIAstat-Dx Syndromic Testing
Oncology
therascreen Solid Tumor
ipsogen Leukemia
Circulating Tumor Cells
DNA Damage Response
Sexual & Reproductive Health
Cervical Cancer Screening
Maternal/Fetal Testing
STI Testing
Sample Processing
Solutions for Laboratory-Developed Tests
Looking for a quick way to design experiments?
Try the Workflow Configurator. A convenient tool to build experimental workflows and find products to match your needs.
Welcome to My QIAGEN
Dashboard
Account
Orders
Log Out
icon_0147_cc_gen_global-s
GB
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia (Plurinational State of)
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
British Virgin Islands
Brunei Darussalam (Brunei)
Bulgaria
Burkina Faso
Burundi
Cabo Verde
Cambodia
Cameroon
Canada
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Cook Islands
Costa Rica
Croatia
Cyprus
Czech Republic
Democratic Republic of the Congo
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Federated States of Micronesia
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island and McDonald Islands
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iraq
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libia
Liechtenstein
Lithuania
Luxembourg
Macao
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Moldova
Monaco
Mongolia
Montserrat
Morocco
Mozambique
Myanmar (Burma)
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
North Macedonia
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Islands
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Rwanda
Saint Helena, Ascension and Tristan da Cunha
Saint Kitts and Nevis
Saint Lucia
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
South Korea
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Taiwan
Tajikistan
Tanzania
Thailand
Togo
Tokelau
Timor-Leste
Tonga
Trinidad and Tobago
Tunisia
Türkiye
Turkmenistan
Turks and Caicos Islands
Tuvalu
U.S. Virgin Islands
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
United States of America
Uruguay
Uzbekistan
Vanuatu
Vatican City
Venezuela
Vietnam
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
icon_0058_speech_bubble-s
ZH
Chinese (Simplified, PRC)
Japanese (Japan)
Korean (Korea)
French
German
Spanish
English
Welcome to QIAGEN!
You can accept or revoke the cookies used on this website at any time with the selection below or by adjusting your cookie settings. For complete details about our cookies, see our
Cookie Policy
.
Customize
Only necessary
Accept all
分子生物学资源中心
新实验室
QIAGEN
Applications & Insights
分子生物学研究
新实验室
QIAGEN 新实验室计划,助力您取得成功
QIAGEN 在客户刚起步时提供助力。无论您是刚刚获得研究资助,还是正在创办一家公司,您都希望确保您的新实验室配备最好的设备和技术。做得恰到好处是迈向成功的重要一步。我们的新实验室计划旨在使您获得全面的支持、教育内容和特殊优惠,从而帮助您加快创新研究。选择一个适合您的计划。
选择您需要的计划
学术性新实验室启动计划
当您第一次开始学术研究时,让 QIAGEN 成为您的合作伙伴。通过我们的“新实验室启动计划”,可以让您快速启动和运行。该计划可以促进您的学术研究,并帮助您保持在预算范围内。
现在开始
生物技术加速器计划
让 QIAGEN 成为您的合作伙伴,帮助您的初创公司起步。通过我们的“生物技术加速器计划”,您将获得全面的支持,以推动您的研究和业务发展的每一步。
现在开始
关于新实验室启动计划的常见问题解答
哪些实验室符合参加新实验室计划的条件?
北美和 EMEA 地区专门从事学术研究或工业生物技术产品开发的新实验室符合参加该计划的条件。请在此页面上选择相关计划,然后填写表格进行注册。注册后,销售代表将与您联系以获取更多信息。
该计划有哪些优势?
注册并被接受加入该计划的实验室将享受各种优惠和特别优惠,这将有助于支持新实验室的建立,并可以加速研究。优惠、条款和条件根据您所在的地区而有所变化,具体请咨询 QIAGEN 销售代表。
为什么与 QIAGEN 合作?
QIAGEN 为分子生物学研究和各种应用提供领先的产品。当您与我们合作时,您就是在与行业领导者合作。从试剂盒、耗材和试剂到完整的工作流程和仪器,我们的科学专家可以为您提供加速研究所需的全面支持。